Farack U M, Reiter J, Gross M, Moroder L, Wünsch E, Loeschke K
Medizinische Klinik Innenstadt, University of Munich, FRG.
Scand J Gastroenterol Suppl. 1987;139:32-6. doi: 10.3109/00365528709089772.
The effect of vasoactive intestinal peptide (VIP), secretin, and VIP-secretin (Ala4, Val5-secretin) on the net movements of sodium, potassium, fluid, and mucus was investigated in the rat colon perfused in vivo. Peptides (1-100 micrograms/kg.h) were infused intra-arterially. VIP influenced electrolyte and fluid movements at a threshold dose 10- to 100-fold lower than secretin, whereas the secretory efficacy was not significantly different. Replacing the NH2-terminal hexapeptide of secretin by that of VIP did not markedly alter the effect of secretin. Mucus output was stimulated weakly by all three peptides. The results indicate that the larger colonic secretory activity of VIP as compared to secretin is not primarily due to the difference in their NH2-terminal sequence but probably requires the intact molecule.
在体内灌注的大鼠结肠中,研究了血管活性肠肽(VIP)、促胰液素及VIP-促胰液素(丙氨酸⁴、缬氨酸⁵-促胰液素)对钠、钾、液体及黏液净移动的影响。肽(1-100微克/千克·小时)通过动脉内输注。VIP影响电解质和液体移动的阈值剂量比促胰液素低10至100倍,而分泌效力无显著差异。用VIP的氨基末端六肽取代促胰液素的该六肽并未显著改变促胰液素的作用。所有三种肽对黏液分泌的刺激作用较弱。结果表明,与促胰液素相比,VIP较大的结肠分泌活性并非主要归因于它们氨基末端序列的差异,而可能需要完整的分子。